Byoung Geol Choi Selected Research

oxidized low density lipoprotein

1/2020	Risk of insulin resistance with statin therapy in individuals without dyslipidemia: A propensity-matched analysis in a registry population.
12/2019	The low-density lipoprotein cholesterol lowering is an ineffective surrogate marker of statin responsiveness to predict cardiovascular outcomes: The 10-year experience of matched population (a STROBE-compliant article).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Byoung Geol Choi Research Topics

Disease

44	Myocardial Infarction 05/2024 - 09/2016
33	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 11/2013
15	Thrombosis (Thrombus) 05/2024 - 08/2018
15	ST Elevation Myocardial Infarction 01/2024 - 12/2017
15	Coronary Vasospasm (Coronary Artery Vasospasm) 03/2023 - 09/2012
14	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 12/2011
14	Diabetes Mellitus 01/2023 - 09/2012
10	Death (Near-Death Experience) 05/2024 - 01/2018
9	Non-ST Elevated Myocardial Infarction 01/2024 - 01/2018
9	Stroke (Strokes) 01/2023 - 09/2016
8	Chest Pain (Chest Pains) 02/2024 - 09/2012
7	Spasm (Spasms) 11/2018 - 12/2011
6	Hypertension (High Blood Pressure) 07/2023 - 09/2012
6	Heart Failure 01/2023 - 01/2019
4	Pathologic Constriction (Stenosis) 01/2022 - 01/2018
3	Coronary Stenosis (Coronary Artery Stenosis) 02/2024 - 07/2017
3	Dyslipidemias (Dyslipidemia) 02/2024 - 12/2019
3	Hemorrhage 01/2023 - 01/2020
3	Chronic Limb-Threatening Ischemia 01/2023 - 03/2015
3	Peripheral Arterial Disease 01/2021 - 12/2011
3	Hematoma 01/2020 - 01/2018
3	Insulin Resistance 01/2020 - 01/2018
1	Ischemia 05/2024
1	Type 2 Diabetes Mellitus (MODY) 02/2024
1	Hyperuricemia 02/2024
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Heart Arrest (Cardiac Arrest) 11/2019
1	Angina Pectoris 01/2019
1	Atrial Fibrillation 01/2019
1	Anemia 12/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2018
1	Prediabetic State (Prediabetes) 06/2018
1	Infarction (Infarctions) 04/2018
1	Chronic Renal Insufficiency 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Coronary Occlusion 09/2017
1	Fibrosis (Cirrhosis) 03/2014
1	Inflammation (Inflammations) 03/2014
1	Aortic Valve Stenosis (Aortic Stenosis) 03/2014
1	Hyperlipidemias (Hyperlipidemia) 09/2012

Drug/Important Bio-Agent (IBA)

36	omega-Chloroacetophenone (Mace)IBA 02/2024 - 07/2017
18	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2024 - 12/2011
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 02/2016
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2023 - 01/2016
6	Angiotensin Receptor AntagonistsIBA 07/2023 - 01/2016
4	NitratesIBA 02/2024 - 01/2017
3	Cilostazol (Pletal)FDA LinkGeneric 05/2024 - 09/2020
3	LDL CholesterolIBA 01/2022 - 12/2019
3	C-Reactive ProteinIBA 07/2019 - 11/2013
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 06/2019 - 01/2017
2	Uric Acid (Urate)IBA 02/2024 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2024 - 09/2012
2	Clopidogrel (Plavix)FDA Link 11/2023 - 09/2020
2	Angiotensin II Type 1 Receptor BlockersIBA 07/2023 - 01/2020
2	CholesterolIBA 01/2022 - 01/2020
2	Atorvastatin (Lipitor)FDA Link 01/2021 - 01/2018
2	Antihypertensive Agents (Antihypertensives)IBA 06/2020 - 01/2015
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2018
2	oxidized low density lipoproteinIBA 01/2020 - 12/2019
2	Phenobarbital (Luminal)FDA Link 10/2019 - 07/2013
2	Hemoglobins (Hemoglobin)IBA 12/2018 - 06/2018
2	Air Pollutants (Pollutants, Air)IBA 01/2018 - 06/2017
2	LipidsIBA 11/2013 - 09/2012
1	Everolimus FDA Link 05/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2024
1	Sirolimus (Rapamycin)FDA Link 04/2024
1	PolymersIBA 04/2024
1	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2024
1	Metformin (Glucophage)FDA LinkGeneric 02/2024
1	TESIBA 02/2024
1	Particulate MatterIBA 01/2024
1	MetalsIBA 01/2023
1	nitinolIBA 01/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	BESIBA 01/2021
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2020
1	Insulin (Novolin)FDA Link 01/2020
1	FibrinIBA 10/2019
1	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2018
1	Glucose (Dextrose)FDA LinkGeneric 06/2018
1	Parasympatholytics (Antispasmodics)IBA 04/2018
1	Trimetazidine (Vastarel)IBA 04/2018
1	pitavastatin (itavastatin)FDA Link 01/2018
1	Lipoprotein(a)IBA 01/2018
1	Diltiazem (Cardizem)FDA LinkGeneric 01/2017
1	Vasodilator Agents (Vasodilators)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	Triglycerides (Triacylglycerol)IBA 12/2011

Therapy/Procedure

31	Percutaneous Coronary Intervention 05/2024 - 04/2015
21	Drug-Eluting Stents 05/2024 - 06/2017
18	Stents 05/2024 - 08/2018
17	Therapeutics 02/2024 - 12/2011
4	Surgical Amputation (Amputations) 01/2023 - 03/2015
1	Secondary Prevention 01/2021
1	Limb Salvage 01/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018